Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: LaserSight

This article was originally published in The Gray Sheet

Executive Summary

LaserSight: Company will focus resources on its laser platform for refractive surgery after gaining approximately $13 mil. from the sale of two of their subsidiaries, MEC Health Care and LSI Acquisition, to Vision Twenty-One. The deal, announced Dec. 31, gives LaserSight $6.5 mil. paid in cash at closing and about $6.5 mil. paid in common stock of Vision Twenty-One. The company estimated after-tax gain of $1.5 mil. to $2 mil. from the transaction, which is subject to post-closing adjustments. MEC Health Care administers HMO and self-insured vision plans; LSI Acquisition is a practice management company that oversees the ophthalmic business known as the Northern New Jersey Eye Institute...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009373

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel